Search research articles
Contact Us
Filters
Showing results (11-20 of 78) with videos related to
Page
of 8
Sort By:
The Oncologist
|
July 11, 2026
Utilizing Micro-RNA-371a-3p for Recurrence Prediction in Clinical Stage I Testicular Cancer
Richard S Matulewicz, Andrea Knezevic, Adam Levin, et al.
European Urology
|
October 3, 2018
The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer
Nick van Dijk, Samuel A Funt, Christian U Blank, et al.
Urology
|
January 9, 2023
Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract
Sherri M Donat, Yukio Sonoda, Hikmat Al-Ahmadie, et al.
The Journal of Urology
|
September 6, 2023
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum
Richard S Matulewicz, Nicole Benfante, Samuel A Funt, et al.
The American Journal of Cardiology
|
February 15, 2011
Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation
Andrew B Goldstone, Joanna Chikwe, Sean P Pinney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2018
Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out
Rune A W van de Wetering, Stefan Sleijfer, Darren R Feldman, et al.
Investigational New Drugs
|
June 27, 2022
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
Nabil Adra, David J Vaughn, Lawrence H Einhorn, et al.
Clinical Genitourinary Cancer
|
September 22, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection
Fady Baky, Nicole Liso, Brandon Williams, et al.
The Journal of Urology
|
July 7, 2025
Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors
Richard S Matulewicz, Melissa Assel, Andrew J Vickers, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
April 20, 2023
Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study
Michael A Hoyt, Ashley Wei-Ting Wang, Raymond Carrillo Ceja, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 78) with videos related to
Sort By:
Page
of 8
The Oncologist
|
July 11, 2026
Utilizing Micro-RNA-371a-3p for Recurrence Prediction in Clinical Stage I Testicular Cancer
Richard S Matulewicz, Andrea Knezevic, Adam Levin, et al.
European Urology
|
October 3, 2018
The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer
Nick van Dijk, Samuel A Funt, Christian U Blank, et al.
Urology
|
January 9, 2023
Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract
Sherri M Donat, Yukio Sonoda, Hikmat Al-Ahmadie, et al.
The Journal of Urology
|
September 6, 2023
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum
Richard S Matulewicz, Nicole Benfante, Samuel A Funt, et al.
The American Journal of Cardiology
|
February 15, 2011
Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation
Andrew B Goldstone, Joanna Chikwe, Sean P Pinney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2018
Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out
Rune A W van de Wetering, Stefan Sleijfer, Darren R Feldman, et al.
Investigational New Drugs
|
June 27, 2022
A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors
Nabil Adra, David J Vaughn, Lawrence H Einhorn, et al.
Clinical Genitourinary Cancer
|
September 22, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection
Fady Baky, Nicole Liso, Brandon Williams, et al.
The Journal of Urology
|
July 7, 2025
Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors
Richard S Matulewicz, Melissa Assel, Andrew J Vickers, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine
|
April 20, 2023
Goal-Focused Emotion-Regulation Therapy (GET) in Young Adult Testicular Cancer Survivors: A Randomized Pilot Study
Michael A Hoyt, Ashley Wei-Ting Wang, Raymond Carrillo Ceja, et al.
Page
of 8